Liposomal doxorubicin and weekly paclitaxel in the treatment of metastatic breast cancer
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cancer Research,Pharmacology (medical),Pharmacology,Oncology
Reference18 articles.
1. Combined doxorubicin and paclitaxel in advanced breast cancer: Effective and cardiotoxic
2. Paclitaxel by 3-hour infusion in combination with bolus doxorubicin in women with untreated metastatic breast cancer: high antitumor efficacy and cardiac effects in a dose-finding and sequence-finding study.
3. Phase II Trial of Doxorubicin and Paclitaxel Plus Granulocyte Colony-Stimulating Factor in Metastatic Breast Cancer: An Eastern Cooperative Oncology Group Study
Cited by 57 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Research progress of tumor‐derived extracellular vesicles in the treatment of malignant pleural effusion;Cancer Medicine;2022-07-21
2. Extracellular Vesicles as Intercellular Communication Vehicles in Regenerative Medicine;Extracellular Vesicles - Role in Diseases, Pathogenesis and Therapy;2022-07-20
3. Mini review on emerging methods of preparation of liposome and its application as Liposome drug delivery systems;Open Journal of Pharmacology and Pharmacotherapeutics;2018-10-26
4. Dental pulp stem cells used to deliver the anticancer drug paclitaxel;Stem Cell Research & Therapy;2018-04-12
5. Peptide-based systems for drug delivery;Peptide Applications in Biomedicine, Biotechnology and Bioengineering;2018
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3